Benitec Biopharma (BNTC) Other Gross PP&E Adjustments (2019 - 2025)
Benitec Biopharma (BNTC) has disclosed Other Gross PP&E Adjustments for 7 consecutive years, with $391000.0 as the latest value for Q1 2025.
- Quarterly Other Gross PP&E Adjustments fell 62.55% to $391000.0 in Q1 2025 from the year-ago period, while the trailing twelve-month figure was $391000.0 through Mar 2025, down 62.55% year-over-year, with the annual reading at $1.0 million for FY2024, 65.55% up from the prior year.
- Other Gross PP&E Adjustments hit $391000.0 in Q1 2025 for Benitec Biopharma, down from $1.3 million in the prior quarter.
- In the past five years, Other Gross PP&E Adjustments ranged from a high of $1.3 million in Q4 2024 to a low of $391000.0 in Q1 2025.
- Historically, Other Gross PP&E Adjustments has averaged $748235.3 across 5 years, with a median of $628000.0 in 2022.
- Biggest five-year swings in Other Gross PP&E Adjustments: plummeted 66.87% in 2022 and later surged 66.77% in 2024.
- Year by year, Other Gross PP&E Adjustments stood at $408000.0 in 2021, then surged by 53.92% to $628000.0 in 2022, then soared by 38.38% to $869000.0 in 2023, then soared by 50.86% to $1.3 million in 2024, then plummeted by 70.18% to $391000.0 in 2025.
- Business Quant data shows Other Gross PP&E Adjustments for BNTC at $391000.0 in Q1 2025, $1.3 million in Q4 2024, and $1.3 million in Q3 2024.